NLRC5: a newly discovered MHC class I transactivator (CITA)
- PMID: 22209772
- PMCID: PMC3323719
- DOI: 10.1016/j.micinf.2011.12.007
NLRC5: a newly discovered MHC class I transactivator (CITA)
Abstract
Major histocompatibility complex (MHC) class I and class II are crucial for the function of the human adaptive immune system. An NLR protein, CIITA (MHC class II transactivator), is a master regulator of MHC class II gene expression as well as of some of the genes involved in MHC class II antigen presentation. It has recently been discovered that another member of the NLR protein family, NLRC5, transcriptionally activates MHC class I genes, and thus acts as "CITA" (MHC class I transactivator), a counterpart to CIITA. In addition to MHC class I genes, NLRC5 can induce the expression of β2M, TAP1 and LMP2, essential components of MHC class I antigen presentation. These findings indicate that NLRC5 and CIITA are transcriptional regulators that orchestrate the concerted expression of critical components in the MHC class I and MHC class II pathways, respectively.
Copyright © 2011 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.
Figures


Similar articles
-
Class I transactivator, NLRC5: a central player in the MHC class I pathway and cancer immune surveillance.Immunogenetics. 2019 Mar;71(3):273-282. doi: 10.1007/s00251-019-01106-z. Epub 2019 Jan 31. Immunogenetics. 2019. PMID: 30706093 Review.
-
CITA/NLRC5: A critical transcriptional regulator of MHC class I gene expression.Biofactors. 2016 Jul 8;42(4):349-57. doi: 10.1002/biof.1285. Epub 2016 Apr 18. Biofactors. 2016. PMID: 27087581 Review.
-
NLRC5: a key regulator of MHC class I-dependent immune responses.Nat Rev Immunol. 2012 Dec;12(12):813-20. doi: 10.1038/nri3339. Nat Rev Immunol. 2012. PMID: 23175229 Review.
-
MHC class I transactivator NLRC5 in host immunity, cancer and beyond.Immunology. 2021 Mar;162(3):252-261. doi: 10.1111/imm.13235. Epub 2020 Aug 3. Immunology. 2021. PMID: 32633419 Free PMC article. Review.
-
NLRC5/MHC class I transactivator is a target for immune evasion in cancer.Proc Natl Acad Sci U S A. 2016 May 24;113(21):5999-6004. doi: 10.1073/pnas.1602069113. Epub 2016 May 9. Proc Natl Acad Sci U S A. 2016. PMID: 27162338 Free PMC article.
Cited by
-
Cutting edge: impaired MHC class I expression in mice deficient for Nlrc5/class I transactivator.J Immunol. 2012 Jul 15;189(2):516-20. doi: 10.4049/jimmunol.1200064. Epub 2012 Jun 18. J Immunol. 2012. PMID: 22711889 Free PMC article.
-
Arid2-IR promotes NF-κB-mediated renal inflammation by targeting NLRC5 transcription.Cell Mol Life Sci. 2021 Mar;78(5):2387-2404. doi: 10.1007/s00018-020-03659-9. Epub 2020 Oct 22. Cell Mol Life Sci. 2021. PMID: 33090288 Free PMC article.
-
Nod2: A Critical Regulator of Ileal Microbiota and Crohn's Disease.Front Immunol. 2016 Sep 20;7:367. doi: 10.3389/fimmu.2016.00367. eCollection 2016. Front Immunol. 2016. PMID: 27703457 Free PMC article. Review.
-
NLRC5 affects diet-induced adiposity in female mice and co-regulates peroxisome proliferator-activated receptor PPARγ target genes.iScience. 2023 Mar 2;26(4):106313. doi: 10.1016/j.isci.2023.106313. eCollection 2023 Apr 21. iScience. 2023. PMID: 36968073 Free PMC article.
-
The Dual Immunoregulatory function of Nlrp12 in T Cell-Mediated Immune Response: Lessons from Experimental Autoimmune Encephalomyelitis.Cells. 2018 Aug 27;7(9):119. doi: 10.3390/cells7090119. Cells. 2018. PMID: 30150571 Free PMC article.
References
-
- Germain RN. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell. 1994;76:287–299. - PubMed
-
- Reith W, Mach B. The bare lymphocyte syndrome and the regulation of MHC expression. Annu. Rev. Immunol. 2001;19:331–373. - PubMed
-
- Ting JP, Trowsdale J. Genetic control of MHC class II expression. Cell. 2002;109(Suppl.):S21–33. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials